Aveo Oncology

Korean firm LG Chem buying AVEO Oncology for $566M
Korean firm LG Chem buying AVEO Oncology for $566M
CP WIre
Aveo Oncology
M&A
oncology
cancer
Korea
LG Chem
Flag link:
Korean firm LG Chem buying AVEO Oncology for $566M
Aveo Oncology
M&A
oncology
cancer
Korea
LG Chem
Flag link:
Aveo Oncology's Fotivda receives FDA approval
Aveo Oncology's Fotivda receives FDA approval
Pharma Live
Aveo Oncology
Fotivda
metastatic renal cell carcinoma
FDA
Flag link:
Aveo regains full rights to ficlatuzumab as partner splits before phase 3
Aveo regains full rights to ficlatuzumab as partner splits before phase 3
Fierce Biotech
Aveo Oncology
ficlatuzumab
Biodesix
clinical trials
Flag link:
Aveo gives up on ficlatuzumab in acute myeloid leukemia, citing COVID-19
Aveo gives up on ficlatuzumab in acute myeloid leukemia, citing COVID-19
Fierce Biotech
Aveo Oncology
ficlatuzumab
AML
COVID-19
clinical trials
Flag link:
FDA tells Aveo no, again, for tivozanib as biotech tries to find yet another path forward
FDA tells Aveo no, again, for tivozanib as biotech tries to find yet another path forward
Fierce Biotech
Aveo Oncology
FDA
tivozanib
Flag link:
Renal Cell Carcinoma Space in Focus: Some Key Developments
Renal Cell Carcinoma Space in Focus: Some Key Developments
Yahoo/Zacks.com
renal cell carcinoma
kidney cancer
Exelixis
Roche
Merck
Aveo Oncology
Flag link:
After falling short on prelim OS data, EMA tells Aveo it wants to see something better on its long suffering tivo this summer — or else
After falling short on prelim OS data, EMA tells Aveo it wants to see something better on its long suffering tivo this summer — or else
Endpoints
Aveo Oncology
tivozanib
EMA
Europe
Flag link:
Aveo Oncology Stock Spikes on Rumors of AstraZeneca Acquisition
Aveo Oncology Stock Spikes on Rumors of AstraZeneca Acquisition
BioSpace
AstraZeneca
Aveo Oncology
M&A
Flag link:
Aveo stock plunges after delay in FDA approval submission for cancer drug
Aveo stock plunges after delay in FDA approval submission for cancer drug
Bizjournals
Aveo Oncology
kidney cancer
FDA
tivozanib
advanced renal cell carcinoma
Flag link:
AZ begins liver cancer immunotherapy tie-up with AVEO
AZ begins liver cancer immunotherapy tie-up with AVEO
Pharmaforum
AstraZeneca
Aveo Oncology
cancer immunotherapy
Imfinzi
Fotivda
hepatocellular carcinoma
Flag link:
Here's Why AVEO Oncology Rose as Much as 15% Today
Here's Why AVEO Oncology Rose as Much as 15% Today
Motley Fool
Aveo Oncology
tivozanib
Flag link:
Here's Why AVEO Oncology Fell as Much as 12.7% Today
Here's Why AVEO Oncology Fell as Much as 12.7% Today
Motley Fool
Aveo Oncology
tivozanib
renal cell carcinoma
Flag link:
Aveo's tivozanib finally moving forward after 4-year delay
Aveo's tivozanib finally moving forward after 4-year delay
BioPharma Dive
Aveo Oncology
tivozanib
Flag link:
​Aveo’s kidney cancer drug submitted for approval in Europe
​Aveo’s kidney cancer drug submitted for approval in Europe
Bizjournals.com
Aveo Oncology
kidney cancer
tivozanib
Flag link:
Novartis bets on a slumping Aveo in a $326M cancer deal
Novartis bets on a slumping Aveo in a $326M cancer deal
Fierce Biotech
Novaris
Aveo Oncology
AV-380
Flag link:
Aveo endures yet another FDA setback
Aveo endures yet another FDA setback
Fierce Biotech
Aveo Oncology
FDA
NRP-1 diagnostics
tivozanib
Flag link:
Tivozanib Is the Gift That Keeps On Giving For Aveo
Tivozanib Is the Gift That Keeps On Giving For Aveo
24/7 Wall St
tivozanib
Aveo Oncology
renal cell carcinoma
Flag link:
Aveo set to soar today on news of potential drug approval in Europe
Aveo set to soar today on news of potential drug approval in Europe
Bizjournals.com
tivozanib
Aveo Oncology
Flag link:
Four one-time biotech underdogs are outperforming the market this year
Four one-time biotech underdogs are outperforming the market this year
Bizjournals.com
biotech
Aveo Oncology
Foundation Medicine
InVivo
Ziopharm
Flag link:

Pages